
Work Here?
Harell Data provides an end-to-end scientific AI infrastructure that lets data owners securely share proprietary datasets with AI modelers without exposing raw data. Its platform brings high-performance GPU compute and an orchestration layer directly to the data (compute-to-data) for on-demand training, fine-tuning, and inference, with data lineage tracking so information never leaves the secure environment. Unlike typical data marketplaces, data creators earn a direct share of compute revenue when their datasets are used for model training, creating a tangible monetization path for scientific data. The goal is to accelerate discovery in drug discovery and materials science by removing bottlenecks around data access, organization, and secure collaboration for AI model development.
Industries
Data & Analytics
AI & Machine Learning
Biotechnology
Healthcare
Company Size
1-10
Company Stage
Early VC
Total Funding
$15M
Headquarters
Bellevue, Washington
Founded
2025
See people who can refer or advise you
Help us improve and share your feedback! Did you find this helpful?
Total Funding
$15M
Above
Industry Average
Funded Over
1 Rounds
CoreWeave (CRWV) stock gains momentum on UBS bullish call and cloud partnership. Key highlights. Table of Contents * CoreWeave shares gained approximately 1% during Wednesday's premarket session. * UBS initiated coverage with a Buy recommendation and set a $120 price objective. * The analyst's target suggests potential upside of around 38% from Tuesday's closing price. * A new multi-year cloud services agreement with Harell Data was unveiled. * Significant debt levels and concentrated customer base continue to pose challenges for investors. CoreWeave (CRWV) shares advanced approximately 1% in premarket trading Wednesday, reaching around $87.65 after settling at $86.76 the previous session. The stock posted a 1.6% increase on Tuesday and has climbed roughly 19% year-to-date. The primary driver behind the rally is an optimistic assessment from UBS. Analyst Karl Keirstead launched coverage with a Buy recommendation and established a $120 price objective, signaling approximately 38% appreciation potential from the prior day's close. UBS characterized its stance as contrarian given the prevailing cautious sentiment surrounding CoreWeave among investors. The investment bank believes concerns regarding financial leverage and credit exposure may be nearing their zenith. UBS projects robust AI infrastructure growth. Keirstead contends that the market may be undervaluing the sustained strength of AI computing demand. He anticipates demand will increasingly originate from corporate enterprises alongside major AI model developers. UBS forecasts improved GPU profitability metrics will boost CoreWeave's revenue per gigawatt. The firm projects this metric could ultimately exceed $15 billion, up from approximately $11 billion presently. CoreWeave currently commands a valuation of roughly three times UBS's 2027 revenue projection. Keirstead considers this multiple appealing for a business anticipated to deliver aggressive top-line expansion, though this thesis hinges substantially on sustained AI infrastructure investment. The $120 price objective reflects approximately 3.8 times estimated 2028 revenue. UBS emphasized CoreWeave's track record for infrastructure dependability as a key differentiator in the AI cloud marketplace. CoreWeave's financial structure remains a focal point for stakeholders. The company finalized an expanded $4.2 billion issuance of 2.875% convertible senior notes maturing in 2033 on September 22. Biotech partnership provides secondary boost. CoreWeave unveiled a multi-year collaboration Wednesday with Harell Data. The biotechnology data platform will leverage CoreWeave Cloud for AI model training, customization, and inference operations. Harell Data's technology enables scientists to develop models using proprietary research datasets while maintaining data security. Training operations will utilize Nvidia A100 and Hopper GPU architectures provided by CoreWeave. The partnership furnishes CoreWeave with another enterprise application beyond the major AI laboratories that have fueled significant growth. Financial details of the arrangement were not revealed, making near-term revenue contributions difficult to assess. Primary investment concerns include elevated leverage, increasing borrowing expenses, and customer concentration. UBS observed that approximately 72% of CoreWeave's revenue derives from merely three clients, creating vulnerability to spending fluctuations among a limited number of accounts. CoreWeave additionally confronts questions regarding long-term profitability in AI infrastructure as competitive pressures intensify and capital expenditure demands remain substantial. The company's robust expansion supports the optimistic perspective, but debt and concentration vulnerabilities remain significant considerations. Currently, UBS's $120 price target appears to be the principal catalyst for Wednesday's premarket advance, while the Harell Data partnership offers supplementary positive momentum. CRWV was changing hands near $87.65 ahead of market open. Limited Time Offer Get 3 free stock ebooks. Discover top-performing stocks in AI, Crypto, and Technology with expert analysis. * Top 10 AI Stocks - Leading AI companies * Top 10 Crypto Stocks - Blockchain leaders * Top 10 Tech Stocks - Tech giants
Harell Data has selected CoreWeave to power its secure platform for AI model training through a multi-year agreement. The platform addresses a key challenge: enabling researchers to train AI models on proprietary biotech datasets without accessing or extracting the underlying data. Harell Data's platform brings models to data rather than moving datasets to models. Training runs execute on CoreWeave's NVIDIA A100 and Hopper GPUs whilst raw data remains protected within the platform. Data owners earn revenue shares on training jobs, whilst model builders can list their trained models on Harell's marketplace under a Models as a Service arrangement. "CoreWeave gives us the scale and technical engagement to move at the pace our customers expect," said Saray Covey, head of operations at Harell Data. The platform uses metered compute per run, with validation maintaining data separation by keeping test questions hidden from builders.
Harlan Robins (Photo via Harell Data) Harlan Robins spent years as the co-founder and chief scientific officer of Adaptive Biotechnologies, helping build
Find jobs on Simplify and start your career today
Industries
Data & Analytics
AI & Machine Learning
Biotechnology
Healthcare
Company Size
1-10
Company Stage
Early VC
Total Funding
$15M
Headquarters
Bellevue, Washington
Founded
2025
Find jobs on Simplify and start your career today